» Articles » PMID: 19079944

Not All Cases of Neural-tube Defect Can Be Prevented by Increasing the Intake of Folic Acid

Overview
Journal Br J Nutr
Date 2008 Dec 17
PMID 19079944
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Some countries have introduced mandatory folic acid fortification, whereas others support periconceptional supplementation of women in childbearing age. Several European countries are considering whether to adopt a fortification policy. Projections of the possible beneficial effects of increased folic acid intake assume that the measure will result in a considerable reduction in neural-tube defects (NTD) in the target population. Therefore, the objective of the present study is to evaluate the beneficial effects of different levels of folic acid administration on the prevalence of NTD. Countries with mandatory fortification achieved a significant increase in folate intake and a significant decline in the prevalence of NTD. This was also true for supplementation trials. However, the prevalence of NTD at birth declined to approximately five cases at birth per 10 000 births and seven to eight cases at birth or abortion per 10 000 births. This decline was independent of the amount of folic acid administered and apparently reveals a 'floor effect' for folic acid-preventable NTD. This clearly shows that not all cases of NTD are preventable by increasing the folate intake. The relative decline depends on the initial NTD rate. Countries with NTD prevalence close to the observed floor may have much smaller reductions in NTD rates with folic acid fortification. Additionally, potential adverse effects of fortification on other vulnerable population groups have to be seriously considered. Policy decisions concerning national mandatory fortification programmes must take into account realistically projected benefits as well as the evidence of risks to all vulnerable groups.

Citing Articles

DTYMK is an essential gene in mice and heterozygosity does not cause neural tube defects.

Tiani K, Stover P Arch Biochem Biophys. 2024; 755:109991.

PMID: 38621447 PMC: 11811913. DOI: 10.1016/j.abb.2024.109991.


The urologist's role in bowel management of adult spina bifida: a narrative review.

Sundell M, Koch G, Kaufman M Transl Androl Urol. 2024; 13(1):116-126.

PMID: 38404547 PMC: 10891392. DOI: 10.21037/tau-23-389.


Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review.

Ornoy A, Echefu B, Becker M Int J Mol Sci. 2024; 25(1).

PMID: 38203562 PMC: 10779436. DOI: 10.3390/ijms25010390.


Neural tube defects as a cause of death among stillbirths, infants, and children younger than 5 years in sub-Saharan Africa and southeast Asia: an analysis of the CHAMPS network.

Madrid L, Vyas K, Kancherla V, Leulseged H, Suchdev P, Bassat Q Lancet Glob Health. 2023; 11(7):e1041-e1052.

PMID: 37271162 PMC: 10282076. DOI: 10.1016/S2214-109X(23)00191-2.


Metabolic Analysis of Methylenetetrahydrofolate Reductase Single Nucleotide Polymorphisms (MTHFR 677C<T and MTHFR 1298A<C), Serum Folate and Vitamin B12 in Neural Tube Defects.

Hassan M, Raslan M, Tharwat M, Sakhr H, El-Khateeb E, Sakr S Indian J Clin Biochem. 2023; 38(3):305-315.

PMID: 37234187 PMC: 10205924. DOI: 10.1007/s12291-022-01049-5.